{
  "author": {
    "name": "Brent Eberle",
    "webUrl": "/author/profile/brent-eberle/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 3,
    "social": [],
    "articles": [
      {
        "uri": "/2023/08/18/alternative-pbm-models-4-proven-strategies-to-reduce-drug-spend/",
        "title": "Alternative PBM models: 4 proven strategies to reduce drug spend",
        "byline": "Brent Eberle",
        "kicker": "Research",
        "prettyDate": "August 18, 2023",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/08/Prescription-Drugs-Article-202306051238.jpg",
          "width": "620",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/brent-eberle/",
            "name": "Brent Eberle"
          }
        ],
        "kickerNode": [
          {
            "uri": "/research/",
            "sectionName": "Research"
          }
        ],
        "summary": "Managing utilization growth of high-cost brand products with potential for off-label use helped minimize spend in some of the faster-growing drug categories like migraine and diabetes, says a new report.",
        "body": null
      },
      {
        "uri": "/2021/03/22/how-to-achieve-a-drug-formulary-that-reduces-costs-and-maintains-access-to-care/",
        "title": "How to achieve a drug formulary that reduces costs and maintains access to care",
        "byline": "Brent Eberle",
        "kicker": "Commentary",
        "prettyDate": "March 22, 2021",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/06/pbm-auditing-compliance-pharmacy-shtstk.jpg",
          "width": "620",
          "height": "422"
        },
        "authors": [
          {
            "webUrl": "/author/profile/brent-eberle/",
            "name": "Brent Eberle"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Wasteful drugs could be driving up your pharmacy benefits spend–here's how to evaluate, identify and establish a high-performance formulary.",
        "body": null
      },
      {
        "uri": "/2020/10/01/3-strategies-to-promote-the-value-of-medication-adherence-among-plan-members/",
        "title": "3 strategies to promote the value of medication adherence among plan members",
        "byline": "Brent Eberle",
        "kicker": "Best Practices",
        "prettyDate": "October 01, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/02/2018-11-27-drug-pills-616x372-AB.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/brent-eberle/",
            "name": "Brent Eberle"
          }
        ],
        "kickerNode": [
          {
            "uri": "/best-practices/",
            "sectionName": "Best Practices"
          }
        ],
        "summary": "As the pandemic creates lasting effects on our economy and health care system, the major barriers to medication adherence have worsened.",
        "body": null
      }
    ]
  }
}